Literature DB >> 24237374

Using health technology assessment for informing coverage decisions in Thailand.

Adun Mohara1, Sitaporn Youngkong, Román Pérez Velasco, Pitsaphun Werayingyong, Kumaree Pachanee, Phusit Prakongsai, Sripen Tantivess, Viroj Tangcharoensathien, Jongkol Lertiendumrong, Pongpisut Jongudomsuk, Yot Teerawattananon.   

Abstract

This article aims to illustrate and critically analyze the results from the 1-year experience of using health technology assessment (HTA) in the development of the Thai Universal Coverage health benefit package. We review the relevant documents and give a descriptive analysis of outcomes resulting from the development process in 2009-2010. Out of 30 topics nominated by stakeholders for prioritization, 12 were selected for further assessment. A total of five new interventions were recommended for inclusion in the benefit package based on value for money, budget impact, feasibility and equity reasons. Different stakeholders have diverse interests and capabilities to participate in the process. In conclusion, HTA is helpful for informing coverage decisions for health benefit packages because it enhances the legitimacy of policy decisions by increasing the transparency, inclusiveness and accountability of the process. There is room for improvement of the current use of HTA, including providing technical support for patient representatives and civic groups, better communication between health professionals, and focusing more on health promotion and disease prevention.

Entities:  

Mesh:

Year:  2012        PMID: 24237374     DOI: 10.2217/cer.12.10

Source DB:  PubMed          Journal:  J Comp Eff Res        ISSN: 2042-6305            Impact factor:   1.744


  27 in total

1.  Health Technology Assessment as a Priority-Setting Tool for Universal Health Coverage: The Call for Global Action at the Prince Mahidol Award Conference 2016.

Authors:  Yot Teerawattananon; Alia Luz
Journal:  Pharmacoeconomics       Date:  2016-01       Impact factor: 4.981

2.  Incorporating cost-effectiveness data in a fair process for priority setting efforts Comment on "Use of cost-effectiveness data in priority setting decisions: experiences from the national guidelines for heart diseases in Sweden".

Authors:  Sitaporn Youngkong
Journal:  Int J Health Policy Manag       Date:  2015-04-11

3.  Health technology assessment in India: Reflection & future roadmap.

Authors:  Shankar Prinja; Kavitha Rajsekhar; Vijay Kumar Gauba
Journal:  Indian J Med Res       Date:  2020-11       Impact factor: 2.375

4.  Economic Evaluation of Human Rotavirus Vaccine in Thailand.

Authors:  Surasak Saokaew; Wasana Prasitsuebsai; Gyneth Lourdes Bibera; Kirati Kengkla; Xu-Hao Zhang; Kyu-Bin Oh; Christa Lee
Journal:  Infect Dis Ther       Date:  2019-06-13

5.  Policies and programs to facilitate access to targeted cancer therapies in Thailand.

Authors:  Rosarin Sruamsiri; Dennis Ross-Degnan; Christine Y Lu; Nathorn Chaiyakunapruk; Anita K Wagner
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 6.  Institutionalising health technology assessment: establishing the Medical Technology Assessment Board in India.

Authors:  Laura E Downey; Abha Mehndiratta; Ashoo Grover; Vijay Gauba; Kabir Sheikh; Shankar Prinja; Ravinder Singh; Francoise A Cluzeau; Saudamini Dabak; Yot Teerawattananon; Sanjiv Kumar; Soumya Swaminathan
Journal:  BMJ Glob Health       Date:  2017-06-26

7.  Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".

Authors:  Unni Gopinathan; Trygve Ottersen; Pascale-Renée Cyr; Kalipso Chalkidou
Journal:  Int J Health Policy Manag       Date:  2021-03-14

8.  The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package.

Authors:  Thunyarat Anothaisintawee; Pattara Leelahavarong; Tanapat Ratanapakorn; Yot Teerawattananon
Journal:  Clinicoecon Outcomes Res       Date:  2012-12-06

9.  Genetics and genomics in Thailand: challenges and opportunities.

Authors:  Vorasuk Shotelersuk; Chanin Limwongse; Surakameth Mahasirimongkol
Journal:  Mol Genet Genomic Med       Date:  2014-05-14       Impact factor: 2.183

10.  Development of a Health Screening Package Under the Universal Health Coverage: The Role of Health Technology Assessment.

Authors:  Yot Teerawattananon; Pritaporn Kingkaew; Tanunya Koopitakkajorn; Sitaporn Youngkong; Nattha Tritasavit; Patsri Srisuwan; Sripen Tantivess
Journal:  Health Econ       Date:  2016-01-15       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.